ROUND ROCK, Texas, April 19, 2021 /PRNewswire/ — ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of allergies, announced that the U.S. Food and Drug…
Read MorePollen can raise your risk of getting COVID-19, whether you have allergies or not
Exposure to pollen can raise your risk of developing COVID-19, and it isn’t just a problem for people with allergies, new research released March 9 shows. Plant physiologist Lewis Ziska, a co-author of the new peer-reviewed study and other recent…
Read More